spot_img
HomeMarket News & Opportunities
Supported byspot_img

Valeant from Canada takes over PharmaSwiss for €350 million

Valeant Pharmaceuticals International from Canada and PharmaSwiss S.A. from Switzerland have signed a preliminary agreement on the acquisition of PharmaSwiss S.A.

PharmaSwiss S.A. produces generic drugs, which it sells under its name, and non-prescription drugs. Valeant is to pay €350 million for the acquisition.

Supported by

After the sales contract is concluded, PharmaSwiss will have about €38 million in cash and no debt.

Supported by

Source Ekapija.com

Post Views: 19
Suppported byOwner's Engineer
Previous article
Tender for reconstruction of National Museum in Belgrade in April or May
Next article
Eurogas invests EUR 1.2 million in construction of LPG storage in Potisje port in Senta

Related posts

BYD electric cars enter Serbian market with TDV automotive as distributor

Chinese electric car manufacturer BYD has entered the Serbian market, with TDV Automotive as the main importer and distributor. At an event in Sava...

Serbia launches ‘Sustainable Export’ initiative to boost global competitiveness of SMEs

The "Sustainable Export" initiative, aimed at strengthening the domestic economy, particularly small and medium-sized enterprises, in international markets through the integration of sustainable business...

UAE announces participation in EXPO Belgrade 2027 to foster global collaboration

The United Arab Emirates have confirmed their participation in the specialized exhibition EXPO Belgrade 2027. “We are pleased to confirm the participation of the United...
Supported byspot_img
Supported byspot_img

Latest Articles

Load more
Supported byspot_img
Supported byClarion Energy

"It's more important to reach the people that count than to count the people you reach."

Contact us: hello@serbiabusiness.news

Member of Mercados Media NetworkMercados Media logo
error: Content is protected !!